#amyloid plaques

1 story

#alzheimer's disease #biomarkers #blood tests #cognitive decline #donanemab #early diagnosis #fda approval #lecanemab #neurodegenerative disease #primary care #tau protein

New blood tests can spot Alzheimer's earlier than ever
Four FDA-cleared blood tests now detect Alzheimer's disease before symptoms appear, but doctors warn they're not for everyone.
TIME · 3m